Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | TLX | ACAD | ||
| Company | Rayzebio Inc | Telix Pharmaceuticals Limited ADR | Acadia Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 62.49 | 10.75 | 21.46 | ||
| High | 62.50 | 11.11 | 21.93 | ||
| Low | 62.48 | 10.63 | 21.46 | ||
| Latest | 62.49 | 10.90 | 21.94 | ||
| Change | +0.01 | +0.36 | +0.48 | ||
| % Change | +0.02% | +3.42% | +2.24% | ||
| Volume | 282,700 | 164,707 | 321,583 | ||
| 20-Day Average Volume | 318,060 | 237,780 | 1,756,683 | ||
| Previous Close | 62.48 | 11.24 | 21.46 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 9.35 | 21.56 | ||
| 20-Day Raw Stochastic | 95.83% | 85.20% | 58.83% | ||
| 20-Day Relative Strength | 86.10 | 70.43 | 45.77 | ||
| Weighted Alpha | N/A | -18.40 | +19.66 | ||
| Today's Opinion | N/A | 24% Buy | 72% Sell | ||
| Previous Opinion | N/A | 24% Buy | 88% Sell | ||
| Last Month's Opinion | N/A | 56% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | +14.12% since 04/07/26 | -1.97% since 04/07/26 | ||
| Low | 62.42 on 02/16/24 | 9.66 on 04/09/26 | 20.96 on 04/13/26 | ||
| High | 62.51 on 02/22/24 | 11.48 on 04/13/26 | 22.86 on 04/08/26 | ||
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | +40.00% since 03/13/26 | +5.07% since 03/13/26 | ||
| Low | 61.86 on 01/24/24 | 7.76 on 03/16/26 | 19.89 on 03/19/26 | ||
| High | 62.51 on 02/22/24 | 11.48 on 04/13/26 | 22.89 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | +44.23% since 01/14/26 | -19.38% since 01/14/26 | ||
| Low | 22.14 on 11/27/23 | 6.28 on 02/17/26 | 19.89 on 03/19/26 | ||
| High | 62.51 on 02/22/24 | 11.48 on 04/13/26 | 27.81 on 01/23/26 | ||
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | +9.46% since 10/14/25 | +6.36% since 10/14/25 | ||
| Low | 17.95 on 09/26/23 | 6.28 on 02/17/26 | 19.89 on 03/19/26 | ||
| High | 62.51 on 02/22/24 | 11.48 on 04/13/26 | 28.35 on 12/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 3,809,135 | 3,658,823 | ||
| Shares Outstanding, K | 59,920 | 338,891 | 170,495 | ||
| Annual Sales | 0 | 803,790,000 | 1,071,510,000 | ||
| Annual Net Income | -68,600,000 | -7,130,000 | 391,000,000 | ||
| Last Quarter Sales | 0 | N/A | 283,990,000 | ||
| Last Quarter Net Income | -18,190,000 | N/A | 273,570,000 | ||
| 60-Month Beta | N/A | -0.86 | 0.83 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | N/A | 0.16 on 02/25/26 | ||
| Latest Earnings Date | 03/04/24 | 05/21/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 31.51 | ||